Enveric Biosciences Agrees to Sell Cancer-Targeting Cannabinoid-Related Intellectual Property
Go back to Enveric Biosciences Agrees to Sell Cancer-Targeting Cannabinoid-Related Intellectual Property| (NASDAQ: ENVB) | Delayed: 1.35 +0.04 (3.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.31 | 52 Week High | $ | |||
| Open | $1.34 | 52 Week Low | $ | |||
| Day High | $1.35 | P/E | N/A | |||
| Day Low | $1.29 | EPS | $ | |||
| Volume | 100,324 | |||||

